Literature DB >> 24419474

[Retinoids in dermatopharmacology].

P M Amann1, H F Merk, J M Baron.   

Abstract

BACKGROUND: Retinoids are important in regulating cell proliferation and differentiation and play an important role in the body, including the skin.
OBJECTIVES: Our objective is to review the current medical literature regarding use, effects and side-effects of topical and systemic retinoids used for therapy.
METHODS: Pubmed/Medline electronic database was searched for relevant German and English literature.
RESULTS: The group of retinoids used for therapeutic purposes includes both naturally occurring and chemically synthesized vitamin A derivates. Because of their influence on keratinization and epithelial differentiation, as well on the proliferation of benign and malignant keratinocytes, retinoids have found a wide application in the field of dermatopharmacology.
CONCLUSION: Retinoids are among the most efficacious drugs used in the treatment of dermatological disorders and have a wide range of biological effects. Thorough knowledge about side-effects and comprehensive information for the patient are essential for safe treatment with retinoids.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24419474     DOI: 10.1007/s00105-013-2649-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  55 in total

1.  Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.

Authors:  S Walmsley; D W Northfelt; B Melosky; M Conant; A E Friedman-Kien; B Wagner
Journal:  J Acquir Immune Defic Syndr       Date:  1999-11-01       Impact factor: 3.731

2.  Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study.

Authors:  Harald Gollnick; Ulrike Blume-Peytavi; Eörs Lāszlō Szabó; Karl-Gustav Meyer; Petra Hauptmann; Georg Popp; Michael Sebastian; Thomas Zwingers; Christoph Willers; Renate von der Weth
Journal:  J Dtsch Dermatol Ges       Date:  2010-03-12       Impact factor: 5.584

Review 3.  Retinoid metabolism in the skin.

Authors:  T C Roos; F K Jugert; H F Merk; D R Bickers
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

4.  Treatment of cutaneous neoplasia with etretinate in renal transplant recipients.

Authors:  D Shuttleworth; R Marks; P J Griffin; J R Salaman
Journal:  Q J Med       Date:  1988-09

5.  Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.

Authors:  Leslie Baumann; Justin Vujevich; Monica Halem; Lucy K Martin; Francisco Kerdel; Melissa Lazarus; Heather Pacheco; Laura Black; Joy Bryde
Journal:  Cutis       Date:  2005-07

6.  Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro.

Authors:  Jens M Baron; Ruth Heise; William S Blaner; Mark Neis; Sylvia Joussen; Alexandra Dreuw; Yvonne Marquardt; Jean-Hilaire Saurat; Hans F Merk; David R Bickers; Frank K Jugert
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

7.  Etretinate in treatment of actinic keratosis. A double-blind crossover study.

Authors:  M Moriarty; J Dunn; A Darragh; R Lambe; I Brick
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

Review 8.  The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review.

Authors:  Hee Young Kang; Laure Valerio; Philippe Bahadoran; Jean-Paul Ortonne
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

9.  [Systemic therapy of rosacea].

Authors:  M Schaller; K Belge
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

10.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.